| Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP) | The Lancet HIV |  | | 2017 | 412 | 0 |
|
| Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study | European journal of clinical investigation |  | | 2015 | 625 | 0 |
|
| Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon | Open forum infectious diseases |  | | 2014 | 540 | 384 |
|
| Les os des personnes infectées par le VIH sont-ils si fragiles? | Revue médicale suisse | | | 2013 | 654 | 0 |
|
| Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial | Lancet. Infectious diseases | | | 2013 | 975 | 0 |
|
| High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy | HIV medicine | | | 2010 | 639 | 0 |
|
| Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon | BMC public health | | | 2010 | 663 | 282 |
|
